You are here

Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status

[BENGALURU] Pfizer and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the US health agency, speeding up the regulatory review process.

The US-listed shares of the German firm climbed about 10 per cent, while Pfizer'...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes